Literature DB >> 12972608

EBNA-1, a bifunctional transcriptional activator.

Gregory Kennedy1, Bill Sugden.   

Abstract

Transient-transfection assays have been used to identify transcription factors, and genetic analyses of these factors can allow a dissection of their mechanism of activation. Epstein-Barr nuclear antigen 1 (EBNA-1) has been shown to activate transcription from transfected templates, but its ability to activate transcription from nuclear templates has been controversial. We have established cells with integrated EBNA-1-responsive templates and have shown that EBNA-1 activates transcription from these chromatin-embedded templates dose dependently. A mutational analysis of EBNA-1 has identified a domain required for transcriptional activation of integrated templates, but not of transfected templates. The ability of EBNA-1 to activate transcription from both integrated and transfected templates can be inhibited by a derivative of EBNA-1 lacking the amino acids required for activation from integrated templates. EBNA-1's mode of activating transfected templates is therefore genetically distinct from that acting on integrated templates.

Mesh:

Substances:

Year:  2003        PMID: 12972608      PMCID: PMC193932          DOI: 10.1128/MCB.23.19.6901-6908.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  EBNA1 can link the enhancer element to the initiator element of the Epstein-Barr virus plasmid origin of DNA replication.

Authors:  T Middleton; B Sugden
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

2.  A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection.

Authors:  B Sugden; N Warren
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

3.  Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus.

Authors:  D A Wysokenski; J L Yates
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

4.  trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.

Authors:  D Reisman; B Sugden
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

5.  Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus.

Authors:  T Mitchell; B Sugden
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

6.  An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene.

Authors:  T A Gahn; B Sugden
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

7.  Multiple regions within EBNA1 can link DNAs.

Authors:  D Mackey; T Middleton; B Sugden
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

8.  Comparison between growth characteristics of an Epstein--Barr virus (EBV)-genome-negative lymphoma line and its EBV-converted subline in vitro.

Authors:  M Steinitz; G Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

9.  The structure of herpes simplex virus type 1 DNA as probed by micrococcal nuclease digestion.

Authors:  S S Leinbach; W C Summers
Journal:  J Gen Virol       Date:  1980-11       Impact factor: 3.891

10.  Transcription factor loading on the MMTV promoter: a bimodal mechanism for promoter activation.

Authors:  T K Archer; P Lefebvre; R G Wolford; G L Hager
Journal:  Science       Date:  1992-03-20       Impact factor: 47.728

View more
  50 in total

1.  Chromatin profiling of Epstein-Barr virus latency control region.

Authors:  Latasha Day; Charles M Chau; Michael Nebozhyn; Andrew J Rennekamp; Michael Showe; Paul M Lieberman
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

2.  Optimal transactivation by Epstein-Barr nuclear antigen 1 requires the UR1 and ATH1 domains.

Authors:  Gyanendra Singh; Siddhesh Aras; Arnold H Zea; Shahriar Koochekpour; Ashok Aiyar
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

3.  Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells.

Authors:  Asuka Nanbo; Eri Kawanishi; Ryuji Yoshida; Hironori Yoshiyama
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

4.  Efficient replication of Epstein-Barr virus-derived plasmids requires tethering by EBNA1 to host chromosomes.

Authors:  Theresa L Hodin; Tanbir Najrana; John L Yates
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

5.  Interactions between Hsp90 and oncogenic viruses: implications for viral cancer therapeutics.

Authors:  Michael R Defee; Zhiqiang Qin; Lu Dai; Jennifer S Isaacs; Chris H Parsons
Journal:  Am J Cancer Res       Date:  2011-06-05       Impact factor: 6.166

6.  Role for G-quadruplex RNA binding by Epstein-Barr virus nuclear antigen 1 in DNA replication and metaphase chromosome attachment.

Authors:  Julie Norseen; F Brad Johnson; Paul M Lieberman
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

7.  Nucleophosmin contributes to the transcriptional activation function of the Epstein-Barr virus EBNA1 protein.

Authors:  Natasha Malik-Soni; Lori Frappier
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

8.  Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1).

Authors:  Fang Lu; Priyankara Wikramasinghe; Julie Norseen; Kevin Tsai; Pu Wang; Louise Showe; Ramana V Davuluri; Paul M Lieberman
Journal:  Virol J       Date:  2010-10-07       Impact factor: 4.099

9.  CTCF prevents the epigenetic drift of EBV latency promoter Qp.

Authors:  Italo Tempera; Andreas Wiedmer; Jayaraju Dheekollu; Paul M Lieberman
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

10.  Zinc coordination is required for and regulates transcription activation by Epstein-Barr nuclear antigen 1.

Authors:  Siddhesh Aras; Gyanendra Singh; Kenneth Johnston; Timothy Foster; Ashok Aiyar
Journal:  PLoS Pathog       Date:  2009-06-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.